Live Quote · NASDAQOPTHHealthcare· Drug Manufacturers - Specialty & Generic

Optimi Health Corp.

$4.79▼ 4.39%($-0.22)
TickerSpark Score
45/100
▌ Weak
50
Valuation
20
Profitability
80
Growth
44
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPTH research report →

52-Week Range33% of range
Low
$4.00
Current
$4.79
High
$6.40
Company Overviewwww.optimihealth.ca

About the company

Based in Princeton, Canada, Optimi Health Corp. , established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners.

CEO
Dane Stevens
IPO
2026
Employees
6
HQ
Princeton, BC, CA

Price Chart

+41.30% · this period
$8.61$5.93$3.26Jul 18Jan 16Jul 20

Get TickerSpark's AI analysis on OPTH

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in